11 Sep 2025
Outcome Statement – July 2025 Stakeholder Meeting: Multiple Myeloma
Outcome Statement – July 2025 Stakeholder Meeting: Multiple Myelom
29 Aug 2025
Updated Public Summary Documents from the May 2025 PBAC Meeting
Updated Public Summary Documents from the May 2025 PBAC Meeting
08 Aug 2025
Advice regarding Xolair (omalizumab) Claiming
Advice-regarding-xolair-omalizumab-claiming
30 Jul 2025
Agenda for the November 2025 PBAC meeting – 30 July 2025
Agenda for the November 2025 PBAC meeting – 30 July 2025
25 Jul 2025
Review of clinical guidelines and cost estimates for the use of anti-epileptic drugs (AEDs) for the treatment of epilepsy
Review of clinical guidelines and cost estimates for the use of anti-epileptic drugs (AEDs) for the treatment of epilepsy
18 Jul 2025
PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – March 2025 meeting
PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – March 2025 meeting
04 Jul 2025
PBAC Public Summary Documents – March 2025 meeting
The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
